Skip to main content
Science / Explained
SERIES: Reading What Actually MattersArticle 2 of 5
What Purity Percentages Actually Mean

A purity percentage is not a ranking. It is a result produced under a specific method, from a specific sample, under specific conditions. The number is only meaningful inside the full documentation picture.

Purity is usually the number people notice first.

It is easy to understand why. A percentage feels simple. It gives the reader something concrete to hold onto. A higher number appears stronger. A lower number appears weaker. The number seems to offer a quick answer.

But purity is not that simple.

A purity percentage is not a complete description of quality. It is a result produced under a specific analytical method, using a specific sample, under specific testing conditions. It tells the reader something important, but not everything.

THE NUMBER

When a COA reports purity, it is usually describing how much of the detected sample corresponds to the intended compound under the method used. In peptide testing, purity and related impurities are important quality attributes because synthetic peptide production can generate closely related impurities, fragments, or byproducts that need to be separated, detected, and understood. (Polypeptide)

That is why purity matters.

But the number should not be read alone.

A purity result becomes meaningful when the reader also knows what method was used, whether identity was confirmed, whether the test is batch-specific, and whether the report provides enough context to interpret the result. Without that context, the number can create a false sense of clarity.

A high number can look reassuring.

But the real question is how that number was generated.

THE METHOD

Different analytical procedures can produce different kinds of information.

A method used to assess purity is not the same as a method used to confirm identity. A method used to detect one class of impurity may not tell the reader everything about every possible impurity. This is why method validation matters in regulated quality systems. ICH Q2(R2) explains that analytical procedure validation is meant to demonstrate that a procedure is fit for its intended purpose. (U.S. Food and Drug Administration)

That phrase matters: intended purpose.

It means a test must be understood according to what it is designed to measure. A purity number does not automatically answer questions outside the scope of that test. It should be read as one result inside a larger documentation picture.

WHY PURITY IS MISUNDERSTOOD

Purity is misunderstood because people want it to work like a ranking.

One number above another. One source better than another. One decision made simple.

But in peptides, purity is part of a larger quality conversation. The number may reflect synthesis quality, purification discipline, impurity control, analytical method, sample handling, and reporting structure. It is important, but it is not independent from everything that came before it.

This is why two purity numbers that look close may not be equally informative.

One may come with clear identity confirmation, batch traceability, method details, and a complete report. Another may appear as a single percentage without enough context to understand how it was produced.

The number may look similar.

The documentation may not be.

What this means

Purity should be read as a signal, not as the entire answer.

The better question is not only: what is the percentage?

The better question is: what does this percentage represent, how was it measured, and what other documentation supports it?

A purity number can be useful.

But only when it sits inside a clear structure of identity, method, batch connection, and traceability.

Catalyst reports purity inside that structure: identity, method, and batch alongside the number, not the number alone.

The better question is not what the percentage is. It is how that percentage was produced.

Previous
How to Read a COA Without a Science Background
Next
What Third-Party Testing Verifies, and What It Doesn't
References6 sources

How to read these sources

This article uses primary sources and reviews to separate mechanism, human evidence, and context.

Public UpdateNews or announcements
MechanismCell and pathway logic
Show 3 more source types
Official LabelRegulator documents
Human TrialStudies in people
ReviewExpert synthesis
  1. Public Update

    USP reference-standards documentation for synthetic peptide therapeutics

    U.S. Pharmacopeia

    Reference Standards to Support Quality of Synthetic Peptide Therapeutics.

    Used Here For

    Explaining the reference-standard system that defines how a purity percentage should be measured and reported.

    Good For

    Understanding the official quality-standards infrastructure behind reputable peptide manufacturing.

    Not For

    Verifying any single product's actual compliance with these standards.

    PMC / United States Pharmacopeia
  2. Public Update

    FDA guidance for industry: ANDAs for highly purified synthetic peptide drug products

    U.S. Food and Drug Administration

    ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin: Guidance for Industry.

    Used Here For

    Grounding the regulatory definition of 'highly purified' that purity percentages are meant to satisfy.

    Good For

    Understanding the regulatory bar for purity and characterization of synthetic peptide drugs.

    Not For

    Assuming an unapproved peptide product meets this bar just because it cites the standard.

    U.S. Food and Drug Administration
  3. Public Update

    ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

    International Council for Harmonisation

    Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients.

    Used Here For

    Explaining the manufacturing-quality framework that governs how purity is controlled and documented.

    Good For

    The internationally recognized manufacturing-quality framework a credible COA should trace back to.

    Not For

    Confirming any specific manufacturer actually follows this framework.

    database.ich.org
  4. Public Update

    FDA guidance: Q2(R2) Validation of Analytical Procedures

    U.S. Food and Drug Administration

    Q2(R2) Validation of Analytical Procedures.

    Used Here For

    Explaining why the analytical method behind a purity percentage must itself be validated.

    Good For

    Understanding what it means for a lab's test method itself to be validated, not just its result.

    Not For

    Verifying whether a specific lab's method was actually validated.

    U.S. Food and Drug Administration
  5. Public Update

    FDA guidance for industry: Data Integrity and Compliance With Drug CGMP

    U.S. Food and Drug Administration

    Data Integrity and Compliance With Drug CGMP: Guidance for Industry.

    Used Here For

    Explaining the recordkeeping standards that ensure a reported purity percentage is genuine.

    Good For

    Understanding the recordkeeping and data-integrity expectations behind a trustworthy COA.

    Not For

    Confirming any specific document's authenticity — that requires direct verification.

    U.S. Food and Drug Administration
  6. Mechanism

    PolyPeptide technical paper: Control Strategies for Synthetic Therapeutic Peptide APIs, Part I

    PolyPeptide Group

    Control Strategies for Synthetic Therapeutic Peptide APIs, Part I: Analytical Consideration.

    Used Here For

    Illustrating the real analytical steps used to actually measure peptide purity.

    Good For

    Understanding the analytical control practices serious peptide manufacturers use.

    Not For

    Assuming all sellers follow these control strategies.

    Polypeptide